281 related articles for article (PubMed ID: 24672316)
1. Spinal fusion in the next generation: gene and cell therapy approaches.
Barba M; Cicione C; Bernardini C; Campana V; Pagano E; Michetti F; Logroscino G; Lattanzi W
ScientificWorldJournal; 2014; 2014():406159. PubMed ID: 24672316
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cell and gene therapies for spinal fusion.
Gottfried ON; Dailey AT
Neurosurgery; 2008 Sep; 63(3):380-91; discussion 391-2. PubMed ID: 18812950
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Anterior Vertebral Interbody Fusion Using Osteogenic Mesenchymal Stem Cells Transplanted in Collagen Sponge.
Yang W; Dong Y; Hong Y; Guang Q; Chen X
Clin Spine Surg; 2016 May; 29(4):E201-7. PubMed ID: 22576723
[TBL] [Abstract][Full Text] [Related]
4. Randomized clinical trial: expanded autologous bone marrow mesenchymal cells combined with allogeneic bone tissue, compared with autologous iliac crest graft in lumbar fusion surgery.
García de Frutos A; González-Tartière P; Coll Bonet R; Ubierna Garcés MT; Del Arco Churruca A; Rivas García A; Matamalas Adrover A; Saló Bru G; Velazquez JJ; Vila-Canet G; García-Lopez J; Vives J; Codinach M; Rodriguez L; Bagó Granell J; Càceres Palou E
Spine J; 2020 Dec; 20(12):1899-1910. PubMed ID: 32730985
[TBL] [Abstract][Full Text] [Related]
5. Osteogenic protein-1 for long bone nonunion: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2005; 5(6):1-57. PubMed ID: 23074475
[TBL] [Abstract][Full Text] [Related]
6. Lumbar spine fusion by local gene therapy with a cDNA encoding a novel osteoinductive protein (LMP-1).
Boden SD; Titus L; Hair G; Liu Y; Viggeswarapu M; Nanes MS; Baranowski C
Spine (Phila Pa 1976); 1998 Dec; 23(23):2486-92. PubMed ID: 9854747
[TBL] [Abstract][Full Text] [Related]
7. Bone graft and bone graft substitutes in spine surgery: current concepts and controversies.
Grabowski G; Cornett CA
J Am Acad Orthop Surg; 2013 Jan; 21(1):51-60. PubMed ID: 23281471
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic mesenchymal progenitor cells for posterolateral lumbar spine fusion in sheep.
Wheeler DL; Lane JM; Seim HB; Puttlitz CM; Itescu S; Turner AS
Spine J; 2014 Mar; 14(3):435-44. PubMed ID: 24438940
[TBL] [Abstract][Full Text] [Related]
9. Bone grafting alternatives in spinal surgery.
Vaccaro AR; Chiba K; Heller JG; Patel TCh; Thalgott JS; Truumees E; Fischgrund JS; Craig MR; Berta SC; Wang JC;
Spine J; 2002; 2(3):206-15. PubMed ID: 14589495
[TBL] [Abstract][Full Text] [Related]
10. Bone graft substitutes for spine fusion: A brief review.
Gupta A; Kukkar N; Sharif K; Main BJ; Albers CE; El-Amin Iii SF
World J Orthop; 2015 Jul; 6(6):449-56. PubMed ID: 26191491
[TBL] [Abstract][Full Text] [Related]
11. Overview of the biology of lumbar spine fusion and principles for selecting a bone graft substitute.
Boden SD
Spine (Phila Pa 1976); 2002 Aug; 27(16 Suppl 1):S26-31. PubMed ID: 12205416
[TBL] [Abstract][Full Text] [Related]
12. A post-market surveillance analysis of the safety of hydroxyapatite-derived products as bone graft extenders or substitutes for spine fusion.
Barbanti Brodano G; Griffoni C; Zanotti B; Gasbarrini A; Bandiera S; Ghermandi R; Boriani S
Eur Rev Med Pharmacol Sci; 2015 Oct; 19(19):3548-55. PubMed ID: 26502842
[TBL] [Abstract][Full Text] [Related]
13. Autologous mesenchymal stromal cells embedded in tricalcium phosphate for posterolateral spinal fusion: results of a prospective phase I/II clinical trial with long-term follow-up.
Blanco JF; Villarón EM; Pescador D; da Casa C; Gómez V; Redondo AM; López-Villar O; López-Parra M; Muntión S; Sánchez-Guijo F
Stem Cell Res Ther; 2019 Feb; 10(1):63. PubMed ID: 30795797
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of posterolateral spinal fusion using mesenchymal stem cells: differences with or without osteogenic differentiation.
Nakajima T; Iizuka H; Tsutsumi S; Kayakabe M; Takagishi K
Spine (Phila Pa 1976); 2007 Oct; 32(22):2432-6. PubMed ID: 18090081
[TBL] [Abstract][Full Text] [Related]
15. Biology of lumbar spine fusion and use of bone graft substitutes: present, future, and next generation.
Boden SD
Tissue Eng; 2000 Aug; 6(4):383-99. PubMed ID: 10992434
[TBL] [Abstract][Full Text] [Related]
16. Current use of biologic graft extenders for spinal fusion.
Coseo NM; Saldua N; Harrop J
J Neurosurg Sci; 2012 Sep; 56(3):203-7. PubMed ID: 22854588
[TBL] [Abstract][Full Text] [Related]
17. Progenitor cells: role and usage in bone tissue engineering approaches for spinal fusion.
Nguyen LH; Duenas V; Chen MY; Jandial R
Adv Exp Med Biol; 2012; 760():188-210. PubMed ID: 23281521
[TBL] [Abstract][Full Text] [Related]
18. Stem Cells in Spine Surgery.
Hansraj KK
Surg Technol Int; 2016 Oct; 29():348-358. PubMed ID: 27466864
[TBL] [Abstract][Full Text] [Related]
19. What bone graft substitutes should we use in post-traumatic spinal fusion?
Guerado E; Fuerstenberg CH
Injury; 2011 Sep; 42 Suppl 2():S64-71. PubMed ID: 21839997
[TBL] [Abstract][Full Text] [Related]
20. Contemporary alternatives to synthetic bone grafts for spine surgery.
Brandoff JF; Silber JS; Vaccaro AR
Am J Orthop (Belle Mead NJ); 2008 Aug; 37(8):410-4. PubMed ID: 18836599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
